• Report language in the FY 2024 Labor, Health & Human Services (LHHS) Appropriations bill on deadliest cancers Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2024 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2024 Defense Appropriations bill Report language in the FY 2025 Labor, Health & Human Services (LHHS) Appropriations bill on deadliest cancers Funding for the National Institutes of Health, the National Cancer Institute, and the Advanced Research Projects Agency in the FY 2025 LHHS Appropriations bill Continued inclusion of all deadliest cancers in the Congressionally Directed Medical Research Program in the FY 2025 Defense Appropriations bill
• Meeting with HHS supporting patient access consensus recommendations

Duration: May 16, 2018 to present

General Issues: Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid

Spending: about $215,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2018: U.S. Senate, House of Representatives, Office of Science & Technology Policy (OSTP), President of the U.S., Vice President of the U.S., Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)

Affiliated organizations: Deadliest Cancers Coalition